In the Community
Supporting our communities around the world
As a company dedicated to saving lives and improving the quality of life for people with rare and serious conditions, we believe that helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
We also recognise that we have a role to play in contributing to humanitarian programs and relief efforts around the world, and that closer to home, our responsibilities extend to supporting critical needs and sustainable development in our local communities.
To support our focus areas, CSL has developed a global community framework that includes:
Support for Patient Communities
CSL donates 12,000 units of CytoGam®
for NIH clinical trial.
Read More >>
- Enhancing quality of life for patients in the conditions our therapies treat
- Improving access to our biological medicines
For more information on contributions to Patient Groups across our regions
click here >
|Support for Biomedical Communities |
- Advancing knowledge in medical and scientific communities
- Fostering the next generation of medical researchers
CSL Florey Medal winner announced.
Read More >>
|Support for Local Communities |
- Supporting community efforts where we live and work
- Supporting communities in times of emergency
CSL donates to disaster relief efforts in Vanuatu and Nepal.
Read More >>
In seeking to achieve our community objectives, we look for opportunities that utilise our unique capabilities and involve our employees and other stakeholders. We provide monetary or product donations, sponsorships, research and education grants and scholarships as well as in-kind support to worthy and credible non-profit organisations. We enter into strategic partnerships with these organisations where this will enhance the overall effort. We also match and support certain contributions made by our employees to their local communities.
Each CSL business unit works within the community framework to optimise community support relative to its operations. Within our business units, marketing, public affairs and human resources are the key functions usually involved in strategy development and program implementation.
Interactions with Patient Organisations
CSL is totally committed to saving and improving the lives of patients with rare and serious conditions. Supporting and partnering with patient organisations is one key way to fulfil that commitment and CSL has a long and strong history of doing so.
The company provides financial support and shares expertise to help patient organisations fulfil their missions of building patient communities, increasing knowledge, awareness and diagnosis of conditions, and working to assure access to care, including therapies. CSL also gains perspective from these organisations to help guide our efforts to serve patient needs, including better understanding of the burden of a condition, the challenges faced by patients and families, and the role we can play.
CSL’s approach to community contributions, including support for patient organisations, is detailed in Our
Code of Responsible Business Practice (CRBP), which is set by the Board. Along with our values, the CRBP requires our interactions to be ethical, appropriate and professional. Furthermore, our Global Community Contributions Policy, which is set by the Global Corporate Responsibility Steering Committee, provides further guidance around the types of contributions and the reporting/transparency requirements for all community contributions.
CSL provides all contributions with a focus on patient benefit and fully in compliance with local laws and regulations.